A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction

被引:465
作者
Rush, TS
Grant, JA
Mosyak, L
Nicholls, A
机构
[1] Wyeth Ayerst Res, Dept Chem & Screening Sci, Cambridge, MA 02140 USA
[2] AstraZeneca Pharmaceut, EST, Macclesfield SK10 4TG, Cheshire, England
[3] Openeye Sci Software, Santa Fe, NM 87507 USA
关键词
D O I
10.1021/jm040163o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this paper, we describe the first prospective application of the shape-comparison program ROCS (Rapid Overlay of Chemical Structures) to find new scaffolds for small molecule inhibitors of the ZipA-FtsZ protein-protein interaction, a proposed antibacterial target. The shape comparisons are made relative to the crystallographically determined, bioactive conformation of a high-throughput screening (HTS) hit. The use of ROCS led to the identification of a set of novel, weakly binding inhibitors with scaffolds presenting synthetic opportunities to further optimize biological affinity and lacking development issues associated with the HTS lead. These ROCS-identified scaffolds would have been missed using other structural similarity approaches such as ISIS 2D fingerprints. X-ray crystallographic analysis of one of the new inhibitors bound to ZipA reveals that the shape comparison approach very accurately predicted the binding mode. These experimental results validate this use of ROCS for chemotype switching or "lead hopping" and suggest that it is of general interest for lead identification in drug discovery endeavors.
引用
收藏
页码:1489 / 1495
页数:7
相关论文
共 28 条
[1]  
ALBRECHT T, 2002, Patent No. 0230410
[2]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[3]   Antagonists of protein-protein interactions [J].
Cochran, AG .
CHEMISTRY & BIOLOGY, 2000, 7 (04) :R85-R94
[4]   Reoptimization of MDL keys for use in drug discovery [J].
Durant, JL ;
Leland, BA ;
Henry, DR ;
Nourse, JG .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2002, 42 (06) :1273-1280
[5]  
EBERLE M, 2001, Patent No. 0193682
[6]  
EBERLE M, 2002, Patent No. 0253560
[7]   Structure-based design of potent CDK1 inhibitors derived from olomoucine [J].
Furet, P ;
Zimmermann, J ;
Capraro, HG ;
Meyer, T ;
Imbach, P .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2000, 14 (05) :403-409
[8]  
Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO
[9]  
2-K
[10]   A GAUSSIAN DESCRIPTION OF MOLECULAR SHAPE [J].
GRANT, JA ;
PICKUP, BT .
JOURNAL OF PHYSICAL CHEMISTRY, 1995, 99 (11) :3503-3510